Cargando…
Effects of Allopurinol as a xanthine oxidase inhibitor on depressive-like behavior of rats and changes in serum BDNF level
BACKGROUND: Depression is a psychiatric disorder characterized by low mood and loss of interest in daily activities. Allopurinol, a xanthine oxidase blocker, is widely administered for the treatment of hyperuricemia. Recently, its effects on serotonin and depressive like behaviors have been reported...
Autores principales: | Jahromy, Mahsa Hadipour, Baghchesara, Bahareh, Javanshir, Salar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626926/ https://www.ncbi.nlm.nih.gov/pubmed/36340441 http://dx.doi.org/10.1016/j.ibneur.2022.10.004 |
Ejemplares similares
-
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
por: Ryu, Dong-Ryeol
Publicado: (2017) -
Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
por: Tayama, Yoshitaka, et al.
Publicado: (2022) -
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009) -
Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition
por: Li, Yong, et al.
Publicado: (2016) -
Maternal-to-fetal allopurinol transfer and xanthine oxidase suppression in the late gestation pregnant rat
por: Kane, Andrew D, et al.
Publicado: (2013)